Title | Type | SJR | H index | Total Docs. (2003) | Total Docs. (3years) | Total Refs. (2003) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2003) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 13.345 Q1 | 254 | 29 | 68 | 7430 | 2163 | 67 | 27.67 | 256.21 | |
2 | Reviews of Physiology Biochemistry and Pharmacology | journal | 2.919 Q1 | 70 | 20 | 19 | 4722 | 108 | 19 | 6.67 | 236.10 | |
3 | Reviews in Contemporary Pharmacotherapy | journal | 0.471 Q2 | 18 | 1 | 27 | 209 | 34 | 27 | 0.60 | 209.00 | |
4 | Pharmacology and Therapeutics | journal | 3.119 Q1 | 233 | 62 | 196 | 12447 | 1525 | 193 | 7.67 | 200.76 | |
5 | Natural Product Reports | journal | 2.710 Q1 | 211 | 43 | 115 | 6706 | 741 | 113 | 6.77 | 155.95 | |
6 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 4 | 17 | 598 | 3 | 17 | 0.00 | 149.50 | ||
7 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.164 Q1 | 82 | 13 | 45 | 1928 | 159 | 44 | 3.52 | 148.31 | |
8 | Critical Reviews in Toxicology | journal | 1.068 Q1 | 129 | 20 | 64 | 2954 | 239 | 64 | 2.54 | 147.70 | |
9 | Progress in Medicinal Chemistry | journal | 0.872 Q1 | 38 | 8 | 25 | 1155 | 61 | 16 | 2.42 | 144.38 | |
10 | Medicinal Research Reviews | journal | 2.603 Q1 | 150 | 29 | 76 | 4077 | 597 | 76 | 8.13 | 140.59 | |
11 | Studies in Natural Products Chemistry | book series | 0.332 Q3 | 49 | 37 | 146 | 5044 | 91 | 98 | 0.47 | 136.32 | |
12 | CNS and Neurological Disorders - Drug Targets | journal | 0.699 Q2 | 96 | 39 | 43 | 5178 | 82 | 43 | 1.91 | 132.77 | |
13 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.288 Q3 | 45 | 22 | 19 | 2881 | 13 | 17 | 0.68 | 130.95 | |
14 | Annual Review of Pharmacology and Toxicology | journal | 11.847 Q1 | 224 | 25 | 83 | 3063 | 1871 | 82 | 23.20 | 122.52 | |
15 | Progress in Drug Research | book series | 0.776 Q1 | 46 | 25 | 48 | 3042 | 120 | 43 | 1.97 | 121.68 | |
16 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.693 Q1 | 99 | 18 | 23 | 2152 | 137 | 22 | 3.43 | 119.56 | |
17 | Current Vascular Pharmacology | journal | 69 | 33 | 0 | 3801 | 0 | 0 | 0.00 | 115.18 | ||
18 | Infectious Disorders - Drug Targets | journal | 0.668 Q2 | 61 | 33 | 57 | 3759 | 119 | 55 | 2.09 | 113.91 | |
19 | Current Drug Targets: Inflammation and Allergy | journal | 0.161 Q3 | 53 | 27 | 26 | 2956 | 7 | 26 | 0.27 | 109.48 | |
20 | Current Medicinal Chemistry | journal | 1.567 Q1 | 202 | 194 | 341 | 21208 | 1642 | 319 | 4.35 | 109.32 | |
21 | Current Drug Metabolism | journal | 1.339 Q1 | 122 | 38 | 87 | 4033 | 382 | 82 | 4.28 | 106.13 | |
22 | Current Pharmaceutical Biotechnology | journal | 0.723 Q1 | 97 | 39 | 78 | 4027 | 190 | 74 | 2.33 | 103.26 | |
23 | Current Gene Therapy | journal | 1.104 Q1 | 80 | 40 | 58 | 4126 | 234 | 58 | 4.03 | 103.15 | |
24 | Current Cancer Drug Targets | journal | 1.097 Q1 | 103 | 39 | 36 | 3957 | 140 | 36 | 3.89 | 101.46 | |
25 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.906 Q1 | 108 | 41 | 57 | 4139 | 140 | 55 | 2.46 | 100.95 | |
26 | Current Drug Targets | journal | 1.255 Q1 | 119 | 62 | 90 | 6207 | 306 | 83 | 3.09 | 100.11 | |
27 | Expert Opinion on Therapeutic Targets | journal | 0.556 Q2 | 106 | 61 | 145 | 6058 | 209 | 142 | 1.67 | 99.31 | |
28 | Current Topics in Medicinal Chemistry | journal | 1.276 Q1 | 133 | 101 | 122 | 9968 | 531 | 122 | 4.35 | 98.69 | |
29 | Advanced Drug Delivery Reviews | journal | 1.934 Q1 | 366 | 101 | 376 | 9929 | 2293 | 334 | 6.61 | 98.31 | |
30 | Current Pharmaceutical Design | journal | 1.372 Q1 | 183 | 249 | 431 | 24398 | 1995 | 370 | 5.13 | 97.98 | |
31 | Clinical Pharmacokinetics | journal | 1.316 Q1 | 184 | 82 | 236 | 7970 | 1235 | 228 | 4.62 | 97.20 | |
32 | Expert Opinion on Emerging Drugs | journal | 0.268 Q3 | 54 | 38 | 73 | 3673 | 57 | 69 | 0.50 | 96.66 | |
33 | CNS Drug Reviews | journal | 0.648 Q2 | 64 | 22 | 72 | 1957 | 148 | 72 | 2.65 | 88.95 | |
34 | Drug Resistance Updates | journal | 1.502 Q1 | 132 | 33 | 114 | 2929 | 467 | 106 | 5.09 | 88.76 | |
35 | Cellular and Molecular Life Sciences | journal | 3.001 Q1 | 261 | 236 | 561 | 20896 | 3039 | 545 | 5.26 | 88.54 | |
36 | Advances in Antiviral Drug Design | book series | 12 | 7 | 0 | 619 | 0 | 0 | 0.00 | 88.43 | ||
37 | American Journal of Respiratory Medicine | journal | 0.140 Q4 | 34 | 42 | 51 | 3646 | 14 | 45 | 0.27 | 86.81 | |
38 | Expert Opinion on Investigational Drugs | journal | 0.971 Q1 | 117 | 153 | 769 | 13274 | 2287 | 745 | 2.99 | 86.76 | |
39 | Toxicological Reviews | journal | 49 | 23 | 0 | 1905 | 0 | 0 | 0.00 | 82.83 | ||
40 | Drug Metabolism Reviews | journal | 0.975 Q1 | 108 | 20 | 77 | 1644 | 267 | 75 | 3.49 | 82.20 | |
41 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 43 | 20 | 0 | 1615 | 0 | 0 | 0.00 | 80.75 | ||
42 | Mini-Reviews in Medicinal Chemistry | journal | 0.550 Q2 | 107 | 74 | 89 | 5792 | 169 | 89 | 1.90 | 78.27 | |
43 | Expert Opinion on Biological Therapy | journal | 0.869 Q1 | 102 | 116 | 176 | 9049 | 509 | 167 | 2.89 | 78.01 | |
44 | Journal of Environmental Pathology, Toxicology and Oncology | journal | 0.520 Q2 | 50 | 22 | 135 | 1715 | 220 | 133 | 1.30 | 77.95 | |
45 | Handbook of Analytical Separations | book series | 0.185 Q3 | 13 | 15 | 55 | 1162 | 23 | 47 | 0.17 | 77.47 | |
46 | Progress in Pharmaceutical and Biomedical Analysis | book series | 0.138 Q3 | 8 | 17 | 49 | 1231 | 15 | 47 | 0.00 | 72.41 | |
47 | Expert Review of Vaccines | journal | 0.190 Q3 | 105 | 78 | 57 | 5374 | 27 | 53 | 0.47 | 68.90 | |
48 | Molecular Diagnosis and Therapy | journal | 68 | 57 | 172 | 3899 | 289 | 159 | 1.82 | 68.40 | ||
49 | Expert Opinion on Pharmacotherapy | journal | 0.541 Q2 | 93 | 204 | 417 | 13857 | 824 | 403 | 1.90 | 67.93 | |
50 | Side Effects of Drugs Annual | book series | 0.100 Q4 | 9 | 52 | 154 | 3514 | 3 | 154 | 0.02 | 67.58 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®